首页>
外国专利>
FGFR2 INHIBITORS FOR THE TREATMENT OF CHOLANGIOCARCINOMA
FGFR2 INHIBITORS FOR THE TREATMENT OF CHOLANGIOCARCINOMA
展开▼
机译:FGFR2抑制剂治疗胆管癌
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed herein are methods of treating cholangiocarcinoma in a patient comprising: evaluating a biological sample from the patient for the presence of one or more FGFR mutants including at least the FGFR2 SNP C383R; and treating the patient with an FGFR inhibitor if one or more FGFR mutants including at least the FGFR2 SNP C383R are present in the sample.
展开▼
机译:本文公开了治疗患者的胆管癌的方法,其包括:评估来自患者的生物学样品中是否存在一种或多种包括至少FGFR2 SNP C383R的FGFR突变体;如果样品中存在一种或多种至少包含FGFR2 SNP C383R的FGFR突变体,则用FGFR抑制剂治疗患者。
展开▼